Cargando…

Correction: Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics, 2019, 11(9), 478

Detalles Bibliográficos
Autores principales: Kanazawa, Takanori, Kurano, Takumi, Ibaraki, Hisako, Takashima, Yuuki, Suzuki, Toyofumi, Seta, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956310/
https://www.ncbi.nlm.nih.gov/pubmed/31861247
http://dx.doi.org/10.3390/pharmaceutics11120689
_version_ 1783487129817448448
author Kanazawa, Takanori
Kurano, Takumi
Ibaraki, Hisako
Takashima, Yuuki
Suzuki, Toyofumi
Seta, Yasuo
author_facet Kanazawa, Takanori
Kurano, Takumi
Ibaraki, Hisako
Takashima, Yuuki
Suzuki, Toyofumi
Seta, Yasuo
author_sort Kanazawa, Takanori
collection PubMed
description
format Online
Article
Text
id pubmed-6956310
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69563102020-01-23 Correction: Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics, 2019, 11(9), 478 Kanazawa, Takanori Kurano, Takumi Ibaraki, Hisako Takashima, Yuuki Suzuki, Toyofumi Seta, Yasuo Pharmaceutics Correction MDPI 2019-12-17 /pmc/articles/PMC6956310/ /pubmed/31861247 http://dx.doi.org/10.3390/pharmaceutics11120689 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Kanazawa, Takanori
Kurano, Takumi
Ibaraki, Hisako
Takashima, Yuuki
Suzuki, Toyofumi
Seta, Yasuo
Correction: Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics, 2019, 11(9), 478
title Correction: Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics, 2019, 11(9), 478
title_full Correction: Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics, 2019, 11(9), 478
title_fullStr Correction: Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics, 2019, 11(9), 478
title_full_unstemmed Correction: Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics, 2019, 11(9), 478
title_short Correction: Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics, 2019, 11(9), 478
title_sort correction: therapeutic effects in a transient middle cerebral artery occlusion rat model by nose-to-brain delivery of anti-tnf-alpha sirna with cell-penetrating peptide-modified polymer micelles. pharmaceutics, 2019, 11(9), 478
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956310/
https://www.ncbi.nlm.nih.gov/pubmed/31861247
http://dx.doi.org/10.3390/pharmaceutics11120689
work_keys_str_mv AT kanazawatakanori correctiontherapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicellespharmaceutics2019119478
AT kuranotakumi correctiontherapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicellespharmaceutics2019119478
AT ibarakihisako correctiontherapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicellespharmaceutics2019119478
AT takashimayuuki correctiontherapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicellespharmaceutics2019119478
AT suzukitoyofumi correctiontherapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicellespharmaceutics2019119478
AT setayasuo correctiontherapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicellespharmaceutics2019119478